Chemotherapy News and Research

Latest Chemotherapy News and Research

PFDN6 protein could be a new target for colorectal cancer treatment

PFDN6 protein could be a new target for colorectal cancer treatment

Targeted gene therapy may reduce AML burden and protect the heart from cardiotoxicity

Targeted gene therapy may reduce AML burden and protect the heart from cardiotoxicity

Adaptive therapy approach can reduce toxicity and drug resistance in ovarian cancer

Adaptive therapy approach can reduce toxicity and drug resistance in ovarian cancer

Chemotherapy's cognitive side effects tied to gut microbiome disruption

Chemotherapy's cognitive side effects tied to gut microbiome disruption

NCCN survey reveals ongoing shortages in crucial cancer medications

NCCN survey reveals ongoing shortages in crucial cancer medications

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

New enzyme targets hold promise for cancer therapies

New enzyme targets hold promise for cancer therapies

Researchers win $2.78 million grant to harness AI for precision treatment in rectal cancer

Researchers win $2.78 million grant to harness AI for precision treatment in rectal cancer

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Using deep learning to design synthetic soluble versions of cell membrane proteins

Using deep learning to design synthetic soluble versions of cell membrane proteins

AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful

AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Iontronic technology shows promise in slowing malignant brain tumor growth

Iontronic technology shows promise in slowing malignant brain tumor growth

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

Study reveals lasting quality of life inequities in breast cancer patients

Study reveals lasting quality of life inequities in breast cancer patients

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

New recommendations for radiation therapy in HPV-associated oropharyngeal cancer

New recommendations for radiation therapy in HPV-associated oropharyngeal cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.